Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase. Bennett RP, Yoluc Y, Salter JD, Ripp A, et al. Antiviral Res 2023 Sep 8:105716. doi: 10.1016/j.antiviral.2023.105716.

Read + Share

Amedeo Smart

Independent Medical Education

Bennett RP, Yoluc Y, Salter JD, Ripp A, et al. Sangivamycin is preferentially incorporated into viral RNA by the SARS-CoV-2 polymerase. Antiviral Res 2023 Sep 8:105716. doi: 10.1016/j.antiviral.2023.105716.
PMID: 37690700